Premenopausal status | Wish for second-stage oophorectomy within 2 years after salpingectomy (if clear at enrollment) |
Documented class IV or V germline pathogenic variant in the BRCA1, BRCA2, BRIP1, RAD51C, or RAD51D gene | Prior bilateral salpingectomy |
Age 25–40 years for BRCA1, 25–45 years for BRCA2, and 25–50 years for BRIP1, RAD51C, and RAD51D pathogenic variant carriers | Personal history of ovarian, fallopian tube, or peritoneal cancer |
Childbearing completed | Current clinical signs, diagnosis, or treatment for malignant disease |
Presence of at least one fallopian tube | |
Participants may have a personal history of a non-ovarian malignancy | |